These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30548962)

  • 1. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
    Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.
    Bollwein C; Gonҫalves JPL; Utpatel K; Weichert W; Schwamborn K
    Molecules; 2022 May; 27(11):. PubMed ID: 35684402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.
    Kriegsmann M; Casadonte R; Kriegsmann J; Dienemann H; Schirmacher P; Hendrik Kobarg J; Schwamborn K; Stenzinger A; Warth A; Weichert W
    Mol Cell Proteomics; 2016 Oct; 15(10):3081-3089. PubMed ID: 27473201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
    Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.
    Djidja MC; Claude E; Snel MF; Scriven P; Francese S; Carolan V; Clench MR
    J Proteome Res; 2009 Oct; 8(10):4876-84. PubMed ID: 19673544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin-fixed paraffin-embedded tissues.
    Casadonte R; Kriegsmann M; Zweynert F; Friedrich K; Baretton G; Otto M; Deininger SO; Paape R; Belau E; Suckau D; Aust D; Pilarsky C; Kriegsmann J
    Proteomics; 2014 Apr; 14(7-8):956-64. PubMed ID: 24482424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
    Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT
    PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.
    Boskamp T; Lachmund D; Oetjen J; Cordero Hernandez Y; Trede D; Maass P; Casadonte R; Kriegsmann J; Warth A; Dienemann H; Weichert W; Kriegsmann M
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):916-926. PubMed ID: 27836618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma.
    Kazdal D; Longuespée R; Dietz S; Casadonte R; Schwamborn K; Volckmar AL; Kriegsmann J; Kriegsmann K; Fresnais M; Stenzinger A; Sültmann H; Warth A; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800034. PubMed ID: 30216696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 12. MALDI-MSI: A Powerful Approach to Understand Primary Pancreatic Ductal Adenocarcinoma and Metastases.
    Gonçalves JPL; Bollwein C; Schlitter AM; Kriegsmann M; Jacob A; Weichert W; Schwamborn K
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
    Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
    Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer.
    Cordero Hernandez Y; Boskamp T; Casadonte R; Hauberg-Lotte L; Oetjen J; Lachmund D; Peter A; Trede D; Kriegsmann K; Kriegsmann M; Kriegsmann J; Maass P
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700168. PubMed ID: 30520240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-to-Site Reproducibility and Spatial Resolution in MALDI-MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples.
    Ly A; Longuespée R; Casadonte R; Wandernoth P; Schwamborn K; Bollwein C; Marsching C; Kriegsmann K; Hopf C; Weichert W; Kriegsmann J; Schirmacher P; Kriegsmann M; Deininger SO
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800029. PubMed ID: 30408343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of atypical non-functional pancreatic neuroendocrine tumor and pancreatic ductal adenocarcinoma using CT based radiomics.
    He M; Liu Z; Lin Y; Wan J; Li J; Xu K; Wang Y; Jin Z; Tian J; Xue H
    Eur J Radiol; 2019 Aug; 117():102-111. PubMed ID: 31307634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry?
    Buck A; Balluff B; Voss A; Langer R; Zitzelsberger H; Aichler M; Walch A
    Anal Chem; 2016 May; 88(10):5281-9. PubMed ID: 27065343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI Imaging for Proteomic Painting of Heterogeneous Tissue Structures.
    Kriegsmann J; Kriegsmann M; Kriegsmann K; Longuespée R; Deininger SO; Casadonte R
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800045. PubMed ID: 30471204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.